Navigation Links
USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes

ProductsUSA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes
Company GYRUS ACMI
Item USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes
Features 
  • Small outside diameter - Less bleeding for better visualization
  • 19.5 Fr, 22.5 Fr, and 26.1 Fr sheaths - Choice of sheaths to meet percutaneous needs
  • Rotating irrigation port - Added convenience during percutaneous procedures
  • Cannulated obturators - Less traumatic; pass over guidewire
  • 30 cm working length - Extra working length to accommodate obese patients
Description ACMITM MRO™-2004 and MRO™-2005 Rigid Percutaneous Nephroscopes combine small diameter convenience and large working throughput capacity with proven MRO performance. These nephroscopes provide large operating channels with small size sheaths. The MRO™-20 sheaths have rotating irrigation ports for easy positioning during percutaneous procedures. The molded body design has offset optics for comfortable viewing, and the Snap-In Snap-Out® locking mechanism assures quick, secure changes during procedures.
Info GYRUS ACMI
Customer Service: (508) 804-2600
Web site: http://www.acmicorp.com

Related medicine products :

1. Vasculight Elite
2. Vasoseal Elite
3. NIR Elite OTW Stent System
4. NIR Elite Monorail Stent System
5. Sandman Elite
6. The Elite™ Premium Shoulder Instrument Systems
7. Apogee Elite Two-in-One Laser System
8. Elite System II
9. USA Series DUR-8 Elite Durable Flexible Ureteroscope System with Primary and Secondary Deflection
10. USA Elite System™ Rotating Continuous Flow Resectoscopes
11. USA Elite System™ & USA Series™ Grooved VaporTome® Vaporization Electrode
... The PowerLab/8SP is a high-performance data acquisition ... life science research applications that require up ... capable of recording at speeds of up ... to disk, and is compatible with instruments, ...
Three Figure Worth Type Test, this test is used for determining diplopia, suppression or fusion in children. Sturdy chrome flashlight comes with red/green glasses. Requires 3 D batteries which are no...
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
20 foot distance 22-1/2" X 11-1/2". This test for illiterate patients has HOTV letters on one side and Allen figures on the other....
Medicine Products:
(Date:9/4/2015)... AZ (PRWEB) , ... September 05, 2015 , ... ... Artists from China for an exclusive, one-night exhibition of their work at Paradise Valley ... exhibit on Friday, September 18, from 6-9 pm. The artists will be on hand ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Insight Product Development has effectively doubled the size of its annual health tech ... medical device and digital health startups to compete for cash and prizes to ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Providence Fertility Center will host ... their fertility and egg freezing. , Date and Time: October 8, 2015 at Waterman ... This hip and informative event will discuss the basics of female fertility and egg ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and ... rules constantly evolving in the consumer goods industry, it can be difficult for ...
(Date:9/4/2015)... ... September 04, 2015 , ... San ... available at CitiDent. CEREC is a newer method for creating restorations through innovative ... patients by eliminating the need for multiple appointments, CEREC produces restorations with total ...
Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... 2008) − University of Kentucky researchers have discovered a possible ... pressure. , Dr. Lisa Cassis and Dr. Alan Daugherty found ... but also significantly reduced artery-clogging lesions that are the leading ... death worldwide. , "In my many years of atherosclerosis ...
... Feb. 14 Following the,company,s announcement of ... its sports and nutritional product manufacturer subsidiary ... Inc., (OTC Bulletin Board: NNTN) http://www.naturalnutritioninc.com ... split of its common stock.,Each shareholder will ...
... Corp. (NASDAQ: NCST ; TSX: NCS) today announced ... narrowed to $4.0 million, or 22,cents per share, on ... loss,of $10.5 million, or 58 cents per share, on ... net loss for 2007 is primarily attributable to,the combined ...
... TeamStaff, Inc.,(Nasdaq: TSTF ), a national provider ... results for the first,quarter ended December 31, 2007., ... 31, 2007 was,$0.1 million as compared to a loss ... from continuing operations was $0.04 million or,$0.00 per share ...
... Protection ... Against Aetna,s Propofol Decision, NEW YORK, Feb. ... of Propofol, the "gold standard" anesthesia agent available,to patients ... amongst physicians, their associations and consumers.,Today, the Gastroenterologists and ...
... computer-aided detection (CAD) is more efficient than double reading ... in a double reading program, according to a study ... In addition, the readings with CAD had a significantly ... reading method consisted of the mammogram being first read ...
Cached Medicine News:Health News:Natural Nutrition Announces Effectiveness of Forward Split of Common Stock Following 2007 Record Revenue Year 2Health News:NUCRYST Pharmaceuticals announces year-end results 2Health News:NUCRYST Pharmaceuticals announces year-end results 3Health News:NUCRYST Pharmaceuticals announces year-end results 4Health News:NUCRYST Pharmaceuticals announces year-end results 5Health News:NUCRYST Pharmaceuticals announces year-end results 6Health News:NUCRYST Pharmaceuticals announces year-end results 7Health News:NUCRYST Pharmaceuticals announces year-end results 8Health News:NUCRYST Pharmaceuticals announces year-end results 9Health News:NUCRYST Pharmaceuticals announces year-end results 10Health News:NUCRYST Pharmaceuticals announces year-end results 11Health News:NUCRYST Pharmaceuticals announces year-end results 12Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 2Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 3Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 4Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 5Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 6Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 7Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 8Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 9Health News:National Health Care Alliance Welcomes New Members 2Health News:National Health Care Alliance Welcomes New Members 3Health News:National Health Care Alliance Welcomes New Members 4Health News:Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3